FDA to probe saxagliptin’s heart failure risk

The U.S. Food and Drug Administration will investigate the possible association between treatment with the type 2 diabetes drug saxagliptin and an increased rate of hospitalizations for heart failure...

Field of Interest: Endocrinology
Type: News Item

New stroke guidelines focus on women’s risks

Newly released guidelines provide the first evidence-based recommendations for preventing stroke in women. The document addresses the issues that uniquely increase stroke risk in women – pregnancy,...

Field of Interest: Cardiology
Type: News Item

Too much dietary sugar raises CVD mortality

Excess intake of sugar in the diet significantly raises the risk of cardiovascular mortality, independently of other risk factors, according to an analysis of National Health and Nutrition...

Field of Interest: Cardiology
Type: News Item

FDA investigating testosterone’s cardiovascular risks

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Cardiology
Type: News Item

FDA investigating testosterone’s cardiovascular risks

The Food and Drug Administration is reassessing the cardiovascular safety of approved testosterone treatments and urged physicians and patients to report side effects. Two recent observational...

Field of Interest: Geriatrics
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness